Definium Therapeutics, Inc. share price logo

Definium Therapeutics, Inc. Share Price

NASDAQ: DFTX

Mid Cap

$22.65

+0.19

(+0.85%)

as on

Definium Therapeutics, Inc. Stock Performance

as on April 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $22.01
    $23.00
    downward going graph

    2.83%

    Downside

    1.55%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Definium Therapeutics, Inc. share price movements today

Previous Close
$22.46
Open
$22.68
Volume
2.4M
Day's Low - High
$22.01 - $23.00

Definium Therapeutics, Inc. Historical Returns

1 Month Return
+ 24.16 %
3 Month Return
+ 49.24 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Definium Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Definium Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.2B

EPS (TTM)

-1.9355

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-64.06%

Definium Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Definium Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Definium Therapeutics, Inc. image
Definium Therapeutics, Inc.
NA$2.2BNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$42.7B130.51%136.818.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.8B98.57%28.4232.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$36.8BNA129.845.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$78.9B48.43%17.9831.41%

Definium Therapeutics, Inc. Stock’s Investor Sentiment and Interest

Search interest for Definium Therapeutics, Inc. Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-22% versus previous 30 day period

Definium Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
Operating Income
-24
-32
-32
-40
-45
-47
EBITDA
-1
-34
-22
-40
-65
-40
Interest Expense
0
0
0
2
1
9
Depreciation
-
-
-
-
-
-
Income Before Tax
-13
-34
-23
-42
-67
-50
Income Tax Expense
-
-
-
-
-
-
Net Income
-13
-34
-23
-42
-67
-50
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Definium Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
Gross Profit
-
-
-3
0
-
Operating Income
-93
-66
-93
-103
-166
EBITDA
-91
-63
-92
-105
-178
Interest Expense
0
1
0
2
5
Depreciation
2
3
3
0
-
Income Before Tax
-94
-56
-95
-108
-183
Income Tax Expense
-1
-
-
-
-
Net Income
-93
-56
-95
-108
-183
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Definium Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-23
-54
-5
-13
-34
-23
-42
-67
-50
Operating Cash Flow
-20
-16
-19
-17
-25
-29
-29
-29
-41
Investing Cash Flow
-
-
-
-
-
-162
-39
15
37
Financing Cash Flow
2
169
10
69
3
1
19
0
246
Change in Cash
-17
152
-9
52
-21
-190
-49
-13
237

Definium Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
0
-1
-33
-93
-56
-95
-108
-183
Operating Cash Flow
0
0
0
-23
-45
-50
-64
-79
-131
Investing Cash Flow
-3
0
0
-
0
-
-
-
-151
Financing Cash Flow
4
0
0
96
98
59
21
253
267
Change in Cash
0
0
0
73
53
8
-42
174
-15

Insights on Definium Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, DFTX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, DFTX stock has moved up by 24.2%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, DFTX has outperformed top 5 stocks with highest market-cap in its industry

About Definium Therapeutics, Inc.

Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum disorder. The company was formerly known as Mind Medicine (MindMed) Inc. and changed its name to Definium Therapeutics, Inc. in January 2026. Definium Therapeutics, Inc. is headquartered in New York, New York.
OrganisationDefinium Therapeutics, Inc.
HeadquartersOne World Trade Center, New York, NY, United States, 10007
IndustryBiotechnology
CEOMr. Robert Barrow
E-voting on sharesClick here to vote

Key Management of Definium Therapeutics, Inc.

Name

Title

Mr. Leonard Latchman

Co-Founder

Ms. Brandi L. Roberts CPA, M.B.A.

Chief Financial Officer

Mr. Peter Mack

Senior Vice President of Pharmaceutical Development & Operations

Ms. Beth Calitri

Vice President of Corporate Communications

Dr. Daniel Rollings Karlin M.A., M.D.

Chief Medical Officer

Mr. Mark R. Sullivan J.D.

Chief Legal Officer & Corporate Secretary

Dr. Scott M. Freeman M.D.

Co-Founder & Clinical Advisor

Ms. Gitanjali Jain Ogawa

VP & Head of Investor Relations

Ms. Stephanie Fagan M.S.

Chief Corporate Affairs Officer

Mr. Robert Barrow

CEO & Director

FAQs

What is Definium Therapeutics, Inc. share price today?

Definium Therapeutics, Inc. share price today is $22.65 as on at the close of the market. Definium Therapeutics, Inc. share today touched a day high of $23 and a low of $22.01.

What is the 52 week high and 52 week low for Definium Therapeutics, Inc. share?

Definium Therapeutics, Inc. share touched a 52 week high of $ on and a 52 week low of $ on . Definium Therapeutics, Inc. stock price today i.e. is closed at $22.65,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Definium Therapeutics, Inc.'s market capitalisation today?

Definium Therapeutics, Inc. market capitalisation is $0.00T as on .

How to invest in Definium Therapeutics, Inc. Stock (DFTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Definium Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Definium Therapeutics, Inc. Shares that will get you 0.0662 shares as per Definium Therapeutics, Inc. share price of $22.65 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Definium Therapeutics, Inc. Stock (DFTX) from India?

Indian investors can start investing in Definium Therapeutics, Inc. (DFTX) shares with as little as ₹92.768 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in Definium Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Definium Therapeutics, Inc. share’s latest price of $22.65 as on April 18, 2026 at 1:29 am IST, you will get 0.4415 shares of Definium Therapeutics, Inc.. Learn more about fractional shares .